UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review
ASH 2019 Updates in Aggressive NHL: Liso-cel in R/R DLBCL, CD19 Loss and Overcoming Resistance, Targeting CD19 and CD22 & BiTEs
Comments 0
Login to view comments.
Click here to Login
